Oral isotretinoin for acne vulgaris side effects on the ocular surface: Hyaluronic acid and galacto-xyloglucan as treatment for dry eye disease signs and symptoms.

Author: De-Hita-CantalejoConcepción, Martínez-LaraConcepción, Sánchez-GonzálezJosé-María, Sánchez-GonzálezMaría Carmen

Paper Details 
Original Abstract of the Article :
The purpose was to assess the efficacy of 0.4% hyaluronic acid and 0.2% galacto-xyloglucan on the subjective symptoms of dry eye disease and invasive and non-invasive tear film signs in oral isotretinoin for acne vulgaris treatment. A prospective, longitudinal, single-blind, clinical study was perfo...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9353322/

データ提供:米国国立医学図書館(NLM)

Combating Dry Eye: A New Approach to Isotretinoin-Induced Ocular Surface Complications

The desert of dry eye disease can be a harsh and unforgiving landscape, causing discomfort and affecting quality of life. This study explores a potential oasis in this arid terrain, evaluating the efficacy of hyaluronic acid and galacto-xyloglucan for treating dry eye symptoms associated with oral isotretinoin therapy for acne vulgaris. The researchers conducted a prospective, longitudinal study to compare the effects of hyaluronic acid with galacto-xyloglucan (HA-GX) to hyaluronic acid alone (HA) on dry eye signs and symptoms.

HA-GX: A Powerful Duo for Dry Eye Relief

The results revealed that HA-GX demonstrated superior efficacy in reducing subjective dry eye symptoms and improving both invasive and non-invasive tear film parameters. Patients receiving HA-GX experienced a greater decrease in ocular surface disease index and standard patient evaluation of eye dryness scores compared to those receiving HA alone. HA-GX also led to a significant improvement in non-invasive break-up time and a reduction in limbal and bulbar conjunctival redness.

Hope for Isotretinoin Users

This research suggests that HA-GX may offer a promising therapeutic option for treating dry eye disease associated with oral isotretinoin therapy. The findings provide valuable insights into the potential benefits of combining hyaluronic acid with galacto-xyloglucan for alleviating dry eye symptoms and improving ocular surface health.

Dr.Camel's Conclusion

This study offers hope for individuals experiencing dry eye symptoms associated with isotretinoin therapy. HA-GX emerged as a potential oasis in the desert of dry eye, offering a promising approach to combatting this uncomfortable condition. The research provides valuable insights into the potential of HA-GX to improve ocular surface health and enhance the overall well-being of patients using isotretinoin for acne vulgaris.

Date :
  1. Date Completed n.d.
  2. Date Revised 2022-08-09
Further Info :

Pubmed ID

35935781

DOI: Digital Object Identifier

PMC9353322

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.